Stephen P. Schoenberger, PhD
Professor, Laboratory of Cellular Immunology, La Jolla Institute for Immunology, Director of Translational Science, San Diego Center for Precision Immunotherapy, Adjunct Professor, Division of Hematology and Oncology, UCSD School of Medicine
Stephen P. Schoenberger is a translational immunologist working in the area of precision cancer immunotherapy. Leveraging insights made over almost 30 years of fundamental studies on the immunobiology of CD4+ and CD8+ T cells, he now guides an integrated research consortium involving research scientists, physicians, and bioinformaticians working to identify neoantigens (NeoAg) through a novel functional strategy based on validation, rather than prediction. Two clinical trials involving personalized NeoAg-specific personalized cancer vaccines and adoptive cellular therapy are now underway at the UCSD Moores Cancer Center, with additional IIT’s scheduled for 2022.